دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
DISCOVER: much accomplished, but not yet for all
Hans M L Spiegel
doi : 10.1016/S0140-6736(20)31530-0
p214
Abrocitinib for atopic dermatitis: a step forward
Stephan Weidinger,Stefan Schreiber
doi : 10.1016/S0140-6736(20)31284-8
p215
Tapering glucocorticoids in rheumatoid arthritis
Elizabeth R Volkmann
doi : 10.1016/S0140-6736(20)30761-3
p218
France's COVID-19 response: balancing conflicting public health traditions
Laëtitia Atlani-Duault,Franck Chauvin,Yazdan Yazdanpanah,Bruno Lina,Daniel Benamouzig,Lila Bouadma,Pierre Louis Druais,Aymeril Hoang,Marie-Aleth Grard,Denis Malvy,Jean-François Delfraissy
doi : 10.1016/S0140-6736(20)31599-3
p219
A crisis of accountability for women's, children's, and adolescents' health
Joy Phumaphi,Elizabeth Mason,Nicholas Kojo Alipui,Jovana R?os Cisnero,Carol Kidu,Brenda Killen,Giorgi Pkhakadze,Gita Sen,Alicia Ely Yamin,Shyama Kuruvilla
doi : 10.1016/S0140-6736(20)31520-8
p222
Offline: Preparing for a vaccine against COVID-19
Richard Horton
doi : 10.1016/S0140-6736(20)31636-6
p226
Ukrainian health authorities adopt hepatitis C project
Sharmila Devi
doi : 10.1016/S0140-6736(20)31639-1
p228
Kesaveloo Goonaruthnum Naidoo: anti-apartheid campaigner
Georgina Ferry
doi : 10.1016/S0140-6736(20)31595-6
p231
Dupilumab for nasal polyposis
Brian Lipworth,Rory Chan,Chris RuiWen Kuo
doi : 10.1016/S0140-6736(20)30562-6
p233
Dupilumab for nasal polyposis – Authors' reply
Claus Bachert,Leda P Mannent
doi : 10.1016/S0140-6736(20)30563-8
p233
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation
Venkatesh L Murthy,Brahmajee K Nallamothu
doi : 10.1016/S0140-6736(20)31061-8
p235
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation
Frank J Wolters
doi : 10.1016/S0140-6736(20)31062-X
p235
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation
Ben Freedman
doi : 10.1016/S0140-6736(20)31063-1
p236
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation – Authors' reply
Peter A Noseworthy,Zachi I Attia,Rickey E Carter,Xiaoxi Yao,Paul A Friedman
doi : 10.1016/S0140-6736(20)31064-3
p236
Dismantling racism in research
April Joy Damian,Melanie Gonzalez
doi : 10.1016/S0140-6736(20)31534-8
p237
Australia's First Nations' response to the COVID-19 pandemic
Sandra Eades,Francine Eades,Daniel McCaullay,Lesley Nelson,Péta Phelan,Fiona Stanley
doi : 10.1016/S0140-6736(20)31545-2
p237
COVID-19 vaccine affordability and accessibility
Safura Abdool Karim
doi : https://doi.org/10.1016/S0140-6736(20)31540-3
p238
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
Catherine F Houlihan,Nina Vora,Thomas Byrne,Dan Lewer,Gavin Kelly,Judith Heaney,Sonia Gandhi,Moira J Spyer,Rupert Beale,Peter Cherepanov,David Moore,Richard Gilson,Steve Gamblin,George Kassiotis,Laura E McCoy,Charles Swanton,on behalf of the Crick COVID-19 Consortium,Andrew Hayward,Eleni Nastoulion behalf of the SAFER Investigators
doi : 10.1016/S0140-6736(20)31484-7
e6
An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19
Sheila Shaigany,Marlis Gnirke,Allison Guttmann,Hong Chong,Shane Meehan,Vanessa Raabe,Eddie Louie,Bruce Solitar,Alisa Femia
doi : 10.1016/S0140-6736(20)31526-9
e8
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
Kenneth H Mayer,Jean-Michel Molina,Melanie A Thompson,Peter L Anderson,Karam C Mounzer,Joss J De Wet,Edwin DeJesus,Heiko Jessen,Robert M Grant,Peter J Ruane,Pamela Wong,Ramin Ebrahimi,Lijie Zhong,Anita Mathias,Christian Callebaut,Sean E Collins,Moupali Das,Scott McCallister,Diana M Brainard,Cynthia Brinson,Amanda Clarke,Pep Coll,Frank A Post,C Bradley Hare
doi : 10.1016/S0140-6736(20)31065-5
p239
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Eric L Simpson,Rodney Sinclair,Seth Forman,Andreas Wollenberg,Roland Aschoff,Michael Cork,Thomas Bieber,Jacob P Thyssen,Gil Yosipovitch,Carsten Flohr,Nina Magnolo,Catherine Maari,Claire Feeney,Pinaki Biswas,Svitlana Tatulych,Hernan Valdez,Ricardo Rojo
doi : 10.1016/S0140-6736(20)30732-7
p255
DISCOVER: much accomplished, but not yet for all
Hans M L Spiegel
doi : 10.1016/S0140-6736(20)31530-0
p214
Abrocitinib for atopic dermatitis: a step forward
Stephan Weidinger,Stefan Schreiber
doi : 10.1016/S0140-6736(20)31284-8
p215
Tapering glucocorticoids in rheumatoid arthritis
Elizabeth R Volkmann
doi : 10.1016/S0140-6736(20)30761-3
p218
France's COVID-19 response: balancing conflicting public health traditions
Laëtitia Atlani-Duault,Franck Chauvin,Yazdan Yazdanpanah,Bruno Lina,Daniel Benamouzig,Lila Bouadma,Pierre Louis Druais,Aymeril Hoang,Marie-Aleth Grard,Denis Malvy,Jean-François Delfraissy
doi : 10.1016/S0140-6736(20)31599-3
p219
A crisis of accountability for women's, children's, and adolescents' health
Joy Phumaphi,Elizabeth Mason,Nicholas Kojo Alipui,Jovana R?os Cisnero,Carol Kidu,Brenda Killen,Giorgi Pkhakadze,Gita Sen,Alicia Ely Yamin,Shyama Kuruvilla
doi : 10.1016/S0140-6736(20)31520-8
p222
Offline: Preparing for a vaccine against COVID-19
Richard Horton
doi : 10.1016/S0140-6736(20)31636-6
p226
Ukrainian health authorities adopt hepatitis C project
Sharmila Devi
doi : 10.1016/S0140-6736(20)31639-1
p228
Kesaveloo Goonaruthnum Naidoo: anti-apartheid campaigner
Georgina Ferry
doi : 10.1016/S0140-6736(20)31595-6
p231
Dupilumab for nasal polyposis
Brian Lipworth,Rory Chan,Chris RuiWen Kuo
doi : 10.1016/S0140-6736(20)30562-6
p233
Dupilumab for nasal polyposis – Authors' reply
Claus Bachert,Leda P Mannent
doi : 10.1016/S0140-6736(20)30563-8
p233
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation
Venkatesh L Murthy,Brahmajee K Nallamothu
doi : 10.1016/S0140-6736(20)31061-8
p235
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation
Frank J Wolters
doi : 10.1016/S0140-6736(20)31062-X
p235
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation
Ben Freedman
doi : 10.1016/S0140-6736(20)31063-1
p236
An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation – Authors' reply
Peter A Noseworthy,Zachi I Attia,Rickey E Carter,Xiaoxi Yao,Paul A Friedman
doi : 10.1016/S0140-6736(20)31064-3
p236
Dismantling racism in research
April Joy Damian,Melanie Gonzalez
doi : 10.1016/S0140-6736(20)31534-8
p237
Australia's First Nations' response to the COVID-19 pandemic
Sandra Eades,Francine Eades,Daniel McCaullay,Lesley Nelson,Péta Phelan,Fiona Stanley
doi : 10.1016/S0140-6736(20)31545-2
p237
COVID-19 vaccine affordability and accessibility
Safura Abdool Karim
doi : https://doi.org/10.1016/S0140-6736(20)31540-3
p238
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
Catherine F Houlihan,Nina Vora,Thomas Byrne,Dan Lewer,Gavin Kelly,Judith Heaney,Sonia Gandhi,Moira J Spyer,Rupert Beale,Peter Cherepanov,David Moore,Richard Gilson,Steve Gamblin,George Kassiotis,Laura E McCoy,Charles Swanton,on behalf of the Crick COVID-19 Consortium,Andrew Hayward,Eleni Nastoulion behalf of the SAFER Investigators
doi : 10.1016/S0140-6736(20)31484-7
e6
An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19
Sheila Shaigany,Marlis Gnirke,Allison Guttmann,Hong Chong,Shane Meehan,Vanessa Raabe,Eddie Louie,Bruce Solitar,Alisa Femia
doi : 10.1016/S0140-6736(20)31526-9
e8
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
Kenneth H Mayer,Jean-Michel Molina,Melanie A Thompson,Peter L Anderson,Karam C Mounzer,Joss J De Wet,Edwin DeJesus,Heiko Jessen,Robert M Grant,Peter J Ruane,Pamela Wong,Ramin Ebrahimi,Lijie Zhong,Anita Mathias,Christian Callebaut,Sean E Collins,Moupali Das,Scott McCallister,Diana M Brainard,Cynthia Brinson,Amanda Clarke,Pep Coll,Frank A Post,C Bradley Hare
doi : 10.1016/S0140-6736(20)31065-5
p239
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Eric L Simpson,Rodney Sinclair,Seth Forman,Andreas Wollenberg,Roland Aschoff,Michael Cork,Thomas Bieber,Jacob P Thyssen,Gil Yosipovitch,Carsten Flohr,Nina Magnolo,Catherine Maari,Claire Feeney,Pinaki Biswas,Svitlana Tatulych,Hernan Valdez,Ricardo Rojo
doi : 10.1016/S0140-6736(20)30732-7
p255
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
Gerd R Burmester,Frank Buttgereit,Corrado Bernasconi,Jose M ?lvaro-Gracia,Nidia Castro,Maxime Dougados,Cem Gabay,Jacob M van Laar,Jan Michael Nebesky,Attila Pethoe-Schramm,Carlo Salvarani,Marc Y Donath,Markus R Johnon behalf of the SEMIRA collaborators
doi : 0.1016/S0140-6736(20)30636-X
p267
Speechless from pain: migraine with prolonged aura
Simon Fandler-H?fler,Christian Enzinger,Thomas Gattringer
doi : 10.1016/S0140-6736(20)31551-8
e11
The link between kidney disease and cancer: complications and treatment
Jolanta Malyszko,Petra Tesarova,Giovambattista Capasso,Anna Capasso
doi : 10.1016/S0140-6736(20)30540-7
p277
Reckoning with mortality: global health, HIV, and the politics of data
Matthew M Kavanagh,Ingrid T Katz,Charles B Holmes
doi : 10.1016/S0140-6736(20)31046-1
p288
